Clinical Trial: Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Primary Sclerosing Cholangitis
Study Type: INTERVENTIONAL
Official Title: An Open Label, Phase 2 Study to Evaluate the Effect of A3907 on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Adults With Primary Sclerosing Cholangitis (PSC)
Brief Summary:
This study will test a drug called A3907 to see how safe and tolerated it is for treating people with Primary Sclerosing Cholangitis (PSC).
Read more